Quinlan Paul T Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$30,272.90

Insider Activity of Quinlan Paul T

According to the SEC Form 4 filings, Quinlan Paul T, being in a position of

  1. General Counsel at Oruka Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 63505 shares for $6.53M,
    over all time since 2026-03-16, has bought 0 shares, and sold 63505 shares for $6.53M.

Biography of Quinlan Paul T

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $6,528,9425100

Comparison of Insiders on Amount of Buys and Sells

2026-10-20SaleOruka Therapeutics, Inc.
ORKA
General Counsel
9,000
0.0135%
$78.53$706,735+20.9%
2026-09-15SaleOruka Therapeutics, Inc.
ORKA
General Counsel
1,039
0.0018%
$95.71$99,443-8.69%
2026-08-14SaleOruka Therapeutics, Inc.
ORKA
General Counsel
52,000
0.0842%
$108.49$5.64M-17.47%
2026-06-15SaleOruka Therapeutics, Inc.
ORKA
General Counsel
733
0.002%
$69.69$51,083+33.08%
2026-03-16SaleOruka Therapeutics, Inc.
ORKA
General Counsel
733
0.0019%
$41.30$30,273+96.67%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.